Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.42 |
| ▸ | YARS1 | P54577 | 2/20 | 0.41 |
| ▸ | TPH1 | P17752 | 1/20 | 0.41 |
| ▸ | PCNA | P12004 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL16820323 | 0.91 | SLC7A5 (0.63) | SLC7A5TAAR1SLC6A2ALPIPKM | |
| Tyrosine SCHEMBL3789571 | 0.90 | SLC7A5 (0.58) | SLC7A5TAAR1SLC6A2ALPIPKM | |
| SCHEMBL4586624 | 0.88 | ALPI (0.57) | SLC7A5TAAR1SLC6A2ALPIPKM | |
| SCHEMBL4575524 | 0.88 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ALPIPKM | |
| SCHEMBL29040629 | 0.85 | SLC7A5 (0.63) | SLC7A5TAAR1SLC6A2ALPIPKM | |
| Tyrosine SCHEMBL1267119 | 0.84 | SLC7A5 (0.61) | SLC7A5TAAR1SLC6A2ALPIPKM | |
| SCHEMBL17062932 | 0.83 | SLC7A5 (0.59) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL2058586 | 0.83 | SLC7A5 (0.59) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL5598391 | 0.83 | SLC7A5 (0.59) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Lactic Acid SCHEMBL28140583 | 0.83 | SLC7A5 (0.59) | SLC7A5TAAR1SLC6A2ALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023152499-A1 | TREATMENT OF TELANGIECTASIA | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-08-17 | — | — | WO | disclosed |
| US-20230190714-A1 | PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS | POSTREL RICHARD (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2020227588-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | WO | disclosed |
| US-20200354404-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | US | disclosed |
| WO-2019182549-A1 | PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS | POSTREL RICHARD (US) | 2019-09-26 | — | — | WO | disclosed |
| US-10253320-B2 | Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1 | CURNA, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| CN-103732534-B | Cellular structure body and manufacture method thereof | 味之素株式会社 | 2016-09-28 | — | — | CN | disclosed |
| US-8843356-B2 | Computer systems and methods for associating genes with traits using cross species data | MERCK SHARP & DOHME CORP. (US) | 2014-09-23 | — | — | US | disclosed |
| US-8541649-B2 | Brassinosteroid regulated kinases (BRKs) that mediate brassinosteroid signal transduction and uses thereof | CARNEGIE INSTITUTION OF WASHINGTON (US) | 2013-09-24 | — | — | US | disclosed |
| EP-2564865-A1 | Methods of Modulating Cellular Homeostatic Pathways and Cellular Survival | Dana-Farber Cancer Institute, Inc. (US) | 2013-03-06 | — | — | EP | disclosed |
| EP-2315770-A2 | BRASSINOSTEROID REGULATED KINASES (BRKS) THAT MEDIATE BRASSINOSTEROID SIGNAL TRANSDUCTION AND USES THEREOF | Carnegie Institution Of Washington (US) | 2011-05-04 | — | — | EP | disclosed |
| US-20100043097-A1 | Brassinosteroid Regulated Kinases (BRKs) That Mediate Brassinosteroid Signal Transduction and Uses Thereof | CARNEGIE INSTITUTION OF WASHINGTON (US) | 2010-02-18 | — | — | US | disclosed |
| WO-2010011285-A2 | BRASSINOSTEROID REGULATED KINASES (BRKS) THAT MEDIATE BRASSINOSTEROID SIGNAL TRANSDUCTION AND USES THEREOF | CARNEGIE INSTITUTION OF WASHINGTON (US) | 2010-01-28 | — | — | WO | disclosed |
| EP-1641930-A4 | NUCLEIC ACID SEQUENCES ENCODING PROTEINS ASSOCIATED WITH ABIOTIC STRESS RESPONSE AND PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2008-06-11 | — | — | EP | disclosed |
| CN-101039702-A | Heat shock protein as a targeting agent for endothelium-specific in vivo transduction | GEN ELECTRIC (US) | 2007-09-19 | — | — | CN | disclosed |
| EP-1641930-A2 | NUCLEIC ACID SEQUENCES ENCODING PROTEINS ASSOCIATED WITH ABIOTIC STRESS RESPONSE AND PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF Plant Science GmbH (DE) | 2006-04-05 | — | — | EP | disclosed |
| EP-1601974-A2 | DIFFERENTIAL MEGAPLEX IMMUNOASSAY | TCP Innovations Limited (GB) | 2005-12-07 | — | — | EP | disclosed |
| WO-2004092398-A2 | NUCLEIC ACID SEQUENCES ENCODING PROTEINS ASSOCIATED WITH ABIOTIC STRESS RESPONSE AND PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004081025-A2 | DIFFERENTIAL MEGAPLEX IMMUNOASSAY | TCP INNOVATIONS LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |
| US-5171837-A | Treatment of autoimmune diseases | KURARAY CO., LTD. (JP) | 1992-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100043097-A1 | Brassinosteroid Regulated Kinases (BRKs) That Mediate Brassinosteroid Signal Transduction and Uses Thereof | BRSK2, BRSK1, BLK | SLC7A5 4361/4885TAAR1 2688/4885SLC6A2 4819/4885 |
| US-20200354404-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | DNPEP, PEPD, ANPEP | SLC7A5 1891/4885TAAR1 3517/4885SLC6A2 4336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.